Innovative and effective immunosuppressive bitherapy for an unusual paraneoplastic opsoclonus-myoclonus-ataxia syndrome of the adult

Neurologia. 2017 Mar;32(2):122-125. doi: 10.1016/j.nrl.2015.02.005. Epub 2015 Jun 7.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Intravenous*
  • Cyclophosphamide / therapeutic use*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Methylprednisolone / therapeutic use*
  • Middle Aged
  • Neuroprotective Agents / therapeutic use*
  • Opsoclonus-Myoclonus Syndrome / drug therapy*

Substances

  • Immunosuppressive Agents
  • Neuroprotective Agents
  • Cyclophosphamide
  • Methylprednisolone